Atypical ductal hyperplasia: interobserver and intraobserver variability

Ernster, 1997, Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma, J Natl Cancer Inst Monogr, 22, 151, 10.1093/jncimono/1997.22.151 Ashikari, 1974, Proceedings: a clinicopathologic study of atypical lesions of the breast, Cancer, 33, 310, 10.1002/1097-0142(197402)33:2<310::AID-CNCR2820330203>3.0.CO;2-C Ashikari, 1980, A clinicopathologic study of atypical lesions of the breast further follow up, Pathol Res Pract, 166, 481, 10.1016/S0344-0338(80)80246-9 Goldenberg, 1969, Comparative ultrastructure of atypical ductal hyperplasia, intraductal carcinoma, and infiltrating ductal carcinoma of the breast, Cancer, 24, 1152, 10.1002/1097-0142(196912)24:6<1152::AID-CNCR2820240614>3.0.CO;2-5 Wellings, 1975, An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions, J Natl Cancer Inst, 55, 231 Dupont, 1985, Risk factors for breast cancer in women with proliferative breast disease, N Engl J Med, 312, 146, 10.1056/NEJM198501173120303 Beck, 1985, Observer variability in reporting of breast lesions, J Clin Pathol, 38, 1358, 10.1136/jcp.38.12.1358 Palli, 1996, Reproducibility of histological diagnosis of breast lesions: results of a panel in Italy, Eur J Cancer, 32A, 603, 10.1016/0959-8049(95)00609-5 Rosai, 1991, Borderline epithelial lesions of the breast, Am J Surg Pathol, 15, 209, 10.1097/00000478-199103000-00001 Schnitt, 1992, Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria, Am J Surg Pathol, 16, 1133, 10.1097/00000478-199212000-00001 Wells, 1998, Statewide study of diagnostic agreement in breast pathology, J Natl Cancer Inst, 90, 142, 10.1093/jnci/90.2.142 Simpson, 2009, Update on atypical epithelial hyperplasia and ductal carcinoma in situ, Pathology, 41, 36, 10.1080/00313020802568097 Pinder, 2003, The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)—current definitions and classification, Breast Cancer Res, 5, 254, 10.1186/bcr623 Fleiss, 1981 Carpenter, 2005, Kappa statistic, CMAJ, 173, 15, 10.1503/cmaj.1041742 Page, 1985, Atypical hyperplastic lesions of the female breast. A long-term follow-up study, Cancer, 55, 2698, 10.1002/1097-0142(19850601)55:11<2698::AID-CNCR2820551127>3.0.CO;2-A Tavassoli, 1990, A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast, Cancer, 65, 518, 10.1002/1097-0142(19900201)65:3<518::AID-CNCR2820650324>3.0.CO;2-O Bodian, 1993, Reproducibility and validity of pathologic classifications of benign breast disease and implications for clinical applications, Cancer, 71, 3908, 10.1002/1097-0142(19930615)71:12<3908::AID-CNCR2820711218>3.0.CO;2-F Ghofrani, 2006, Discrepancies in the diagnosis of intraductal proliferative lesions of the breast and its management implications: results of a multinational survey, Virchows Arch, 449, 609, 10.1007/s00428-006-0245-y Palazzo, 1998, Hyperplastic ductal and lobular lesions and carcinomas in situ of the breast: reproducibility of current diagnostic criteria among community- and academic- based pathologists, Breast J, 4, 230, 10.1046/j.1524-4741.1998.440230.x Elston, 2000, Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast. European commission working group on breast screening pathology, Eur J Cancer, 36, 1769, 10.1016/S0959-8049(00)00181-7 Bianchi, 1994, Reproducibility of histological diagnoses and diagnostic accuracy of non palpable breast lesions, Pathol Res Pract, 190, 69, 10.1016/S0344-0338(11)80498-X MacGrogan, 2008, Impact of immunohistochemical markers, CK5/6 and E-cadherin on diagnostic agreement in non-invasive proliferative breast lesions, Histopathology, 52, 689, 10.1111/j.1365-2559.2008.03016.x Yeh, 2008, Application of immunohistochemistry to breast lesions, Arch Pathol Lab Med, 132, 349, 10.5858/2008-132-349-AOITBL Otterbach, 2000, Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast, Histopathology, 37, 232, 10.1046/j.1365-2559.2000.00882.x Heatley, 1995, Cytokeratin intermediate filament expression in benign and malignant breast disease, J Clin Pathol, 48, 26, 10.1136/jcp.48.1.26 Purkis, 1990, Antibody markers of basal cells in complex epithelia, J Cell Sci, 97, 39, 10.1242/jcs.97.1.39 Wetzels, 1989, Detection of basement membrane components and basal cell keratin 14 in noninvasive and invasive carcinomas of the breast, Am J Pathol, 134, 571 Lacroix-Triki, 2003, Value of cytokeratin 5/6 immunostaining using D5/16 B4 antibody in the spectrum of proliferative intraepithelial lesions of the breast. A comparative study with 34betaE12 antibody, Virchows Arch, 442, 548, 10.1007/s00428-003-0808-0 Moinfar, 1999, Use of keratin 35betaE12 as an adjunct in the diagnosis of mammary intraepithelial neoplasia-ductal type–benign and malignant intraductal proliferations, Am J Surg Pathol, 23, 1048, 10.1097/00000478-199909000-00007 Douglas-Jones, 2005, Observer variability in the histopathological reporting of core biopsies of papillary breast lesions is reduced by the use of immunohistochemistry for CK5/6, calponin and p63, Histopathology, 47, 202, 10.1111/j.1365-2559.2005.02208.x Gal-Gombos, 2002, Large-needle core biopsy in atypical intraductal epithelial hyperplasia including immunohistochemical expression of high molecular weight cytokeratin: analysis of results of a single institution, Breast J, 8, 269, 10.1046/j.1524-4741.2002.08504.x Beahrs, 1979, Report of the working group to review the National Cancer Institute—American Cancer Society breast cancer detection demonstartion projects, J Natl Cancer Inst, 62, 640 Beahrs, 1979, Diagnosis of minimal breast cancers in the BCDDP: the 66 questionable cases, Cancer, 43, 848, 10.1002/1097-0142(197903)43:3<848::AID-CNCR2820430310>3.0.CO;2-1 Beahrs, 1980, Early detection of breast cancer: results of a screening programme, Ann R Coll Surg Engl, 62, 38 Smart, 1997, Twenty-year follow-up of the breast cancers diagnosed during the Breast Cancer Detection Demonstration Project, CA Cancer J Clin, 47, 134, 10.3322/canjclin.47.3.134 Fisher, 1994, Quality assurance of pathology in clinical trials. The National Surgical Adjuvant Breast and Bowel Project experience, Cancer, 74, 2638, 10.1002/1097-0142(19941101)74:9+<2638::AID-CNCR2820741809>3.0.CO;2-8 Dundar MM, Badve S, Jain R, et al. Computerized analysis of breast microscopic tissues for improved classification of intraductal lesions. IEEE Trans Biomed Eng; 4 February 2011 [e-pub ahead of print].